Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Pop-Busui, R., Sima, A
Together, this work provides a conceptual and experimental framework for developing adjunct therapies aimed at maintaining weight loss by targeting glucocorticoid signaling pathways, addressing a major unmet need in obesity treatment and offering new avenues for improving the long-term efficacy of current pharmacotherapies
Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with bloodbrain barrier leakage and active demyelination
The capacity of these drugs to increase insulin secretion and suppress glucagon release leads not only to better blood sugar control but also to a better cardiovascular profile, putting them in a favorable position in the treatment of type 2 diabetes
US$ 23.53
US$ 23.41
US$ 26.48
US$ 22.74
US$ 27.60
US$ 27.32
US$ 23.85
US$ 29.47
